Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2009
06/30/2009US7553622 Cell suspension containign Dna fragments; extraction; transferring; separating a mixture
06/30/2009US7553621 Separate recognition molecule and target molecule; image before and after treatment to determine specific and non specific bindings between molecules; labeling enzyme has a precipitating product with detectable fluorescent signal or using a chromophore
06/30/2009US7553618 Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir
06/30/2009US7553617 Fusion proteins of bacteriophage coat proteins, and bacteriophage particles are screened against receptors
06/30/2009US7553493 Chlamydia flagellar protein antigen
06/30/2009US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits
06/30/2009US7553483 Chemokine mutants acting as chemokine antagonists
06/30/2009CA2445295C .beta.1,3-galactosyltransferase and dna encoding the same
06/30/2009CA2437656C Polynucleotide constructs for increased lysine production
06/30/2009CA2359318C Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
06/30/2009CA2324970C Improved immunodiagnostic assays using reducing agents
06/30/2009CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
06/30/2009CA2259421C Labelling and selection of molecules
06/30/2009CA2240149C Improved neurospora hosts for the production of recombinant proteins, and methods for producing the same
06/30/2009CA2211118C Stable lipid-comprising drug delivery complexes and methods for their production
06/30/2009CA2189441C Lipases with improved surfactant resistance
06/30/2009CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
06/30/2009CA2135208C Immunoglobulin binding proteins derived from l protein and their uses
06/30/2009CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
06/30/2009CA2108119C Glial mitogenic factors, their preparation and use
06/30/2009CA2095521C Hepatitis c virus asialoglycoproteins
06/30/2009CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
06/25/2009WO2009079606A2 Microrna-induced es-like cells and uses thereof
06/25/2009WO2009079592A2 Modulating immune system development and function through microrna mir-146
06/25/2009WO2009079549A2 Inhibitors of bacterial nitric oxide synthase, and related screening methods
06/25/2009WO2009079548A2 Down-regulation of gene expression using artificial micrornas
06/25/2009WO2009079532A2 Down-regulation of gene expression using artificial micrornas
06/25/2009WO2009079529A2 Drought tolerant plants and related constructs and methods involving genes encoding ferredoxin family proteins
06/25/2009WO2009079481A2 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma
06/25/2009WO2009079474A1 Methods, systems, and computer readable media for facilitating automation of blastocyst microinjection
06/25/2009WO2009079399A2 Method of treating neurodegenerative disease
06/25/2009WO2009079308A2 Composition and method of use of sheep fab phage display library
06/25/2009WO2009079220A2 Recombinant elastase proteins and methods of manufacturing and use thereof
06/25/2009WO2009079185A2 Methods of generating alphavirus particles
06/25/2009WO2009078796A1 Compositions and methods for treatment of autoimmune and allergic diseases
06/25/2009WO2009078687A2 Recombinant microorganism having an ability of using sucrose as a carbon source
06/25/2009WO2009078685A2 Novel sirna structure for minimizing off-target effects and relaxing saturation of rnai machinery and the use thereof
06/25/2009WO2009078470A1 Complex of polysaccharide and double-stranded rna
06/25/2009WO2009078438A1 Microbe complex
06/25/2009WO2009078386A1 Novel method of preparing specimen having excellent abilities to maintain tissue morphology and maintain nucleic acid qualities
06/25/2009WO2009078385A1 Test method for type-2 diabetes using gene polymorphism
06/25/2009WO2009078115A1 A method and an apparatus for determining nucleotide sequence, and a computer program product to be executed by the apparatus
06/25/2009WO2009078108A1 Mutant ilv5 gene and use thereof
06/25/2009WO2009077973A1 Expression cassettes and methods for increasing plant yield
06/25/2009WO2009077731A2 Prolactin fusion proteins
06/25/2009WO2009077618A2 A host cell deficient for murf1 and murf2
06/25/2009WO2009077611A2 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm)
06/25/2009WO2009077547A1 Lipid metabolism protein and uses thereof iii (pyruvate-orthophosphate-dikinase)
06/25/2009WO2009077546A2 Lipid metabolism protein and uses thereof ii (phosphate transporter)
06/25/2009WO2009077545A2 Lipid metabolism protein and uses thereof i (bzip transcription factor)
06/25/2009WO2009077523A2 Improved statin production
06/25/2009WO2009077483A1 Antibodies against human nkg2d and uses thereof
06/25/2009WO2009077479A2 Altering high-density lipoprotein levels through carboxylesterase 1 modulation
06/25/2009WO2009077478A2 Promoters from brassica napus for seed specific gene expression
06/25/2009WO2009077461A1 ω-AMINO CARBOXYLIC ACIDS, ω-AMINO CARBOXYLIC ACID ESTERS, OR RECOMBINANT CELLS WHICH PRODUCE LACTAMS THEREOF
06/25/2009WO2009077406A2 Lipid metabolism proteins, combinations of lipid metabolism proteins and uses thereof
06/25/2009WO2009077175A1 Polypeptide derived from protein a and able to bind pdgf
06/25/2009WO2009077173A2 Dna-encoded chemical libraries
06/25/2009WO2009077134A2 Use of rna for reprogramming somatic cells
06/25/2009WO2009076824A1 Genes encoding major capsid protein l1 of human papilloma virus's
06/25/2009WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
06/25/2009WO2009076711A1 Enzymes and methods for degrading chlorinated s-triazines
06/25/2009WO2009076709A1 Multiple promoter platform for protein production
06/25/2009WO2009061413A3 Hybrid fusion reporter and uses thereof
06/25/2009WO2009061378A3 Variants of bacillus licheniformis alpha-amylase with increased thermostability and/or decreased calcium dependence
06/25/2009WO2009060122A3 Use of oligonucleotides with modified bases as antiviral agents
06/25/2009WO2009058947A3 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof
06/25/2009WO2009058911A3 Preparation and isolation of 5' capped mrna
06/25/2009WO2009055498A3 Mig-7 as a specific anticancer target
06/25/2009WO2009053683A3 Treatment of inflammatory diseases
06/25/2009WO2009049126A3 Synthetic genes encoding cry1ac
06/25/2009WO2009046123A3 Nlrr-1 antagonists and uses thereof
06/25/2009WO2009039300A8 Compositions comprising hif-1 alpha sirna and methods of use thereof
06/25/2009WO2009036228A3 Hepatitis b pre-s2 nucleic acid
06/25/2009WO2009034158A3 Transgenic mice
06/25/2009WO2009011828A4 Methods and compositions useful for modulating drug-induced impairment
06/25/2009WO2009007848A3 Bioactive peptides and method of using same
06/25/2009WO2008142479A3 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus
06/25/2009WO2008133665A3 Global transcription machinery engineering
06/25/2009WO2008116931A3 Polynucleotides for enhancing expression of a polynucleotide of interest
06/25/2009US20090165177 Isopentenyl transferase sequences and methods of use
06/25/2009US20090165175 Methods for high efficiency transformation and regeneration of plant suspension cultures
06/25/2009US20090165174 Cytokinin Oxidase Sequences and Methods of Use
06/25/2009US20090165173 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
06/25/2009US20090165172 Energy crops such as switchgrass modified with agronomic traits
06/25/2009US20090165171 Transgenic Plants Exhibiting Increased Tolerance to Stress and Methods of Generating Same
06/25/2009US20090165170 Phosphatase Stress-Related Proteins and Methods of Use in Plants
06/25/2009US20090165169 regulate the proanthocynanidin biosynthetic pathway and proanthocynanidin biosynthesis in a plant; genetic engineering;
06/25/2009US20090165168 DROUGHT TOLERANT PLANTS AND RELATED CONSTRUCTS AND METHODS INVOLVING GENES ENCODING miR827
06/25/2009US20090165167 Means and Methods to Enhance the Production of Vinblastine and Vincristine in Catharanthus Roseus
06/25/2009US20090165165 Transgenic plants with enhanced agronomic traits
06/25/2009US20090165164 Cotton variety 05h284
06/25/2009US20090165163 Cotton variety 05h210
06/25/2009US20090165162 Cotton variety 03h070
06/25/2009US20090165161 Cotton variety 05z855
06/25/2009US20090165156 Method for increasing the saltwater tolerance of a fish
06/25/2009US20090165154 Genetically engineered ungulates for use as bioreactors for human antibodies; reducing transmission of spongiform encephalopy
06/25/2009US20090165153 Modified gene-silencing RNA and uses thereof
06/25/2009US20090165151 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators
06/25/2009US20090165150 Directed complementation with removable gene of interest
1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 4023